Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-filled Pen B in Type 2 Diabetes
NCT00231725Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, open-label, single-arm trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Primary endpoint: Complaint data on the Pre-filled Pen B at 2 months. Started Sep 2005; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00231725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231725.